2023-11-14T13:37:15-06:00 2022-12-31 042689883 WOLF & COMPANY PC 255 STATE STREET BOSTON MA 02109 990 2022-01-01 851681659 COMMONWEALTH CANCER CONSORTIUM INC COMM 8007579881 101 ROGERS STREET CAMBRIDGE MA 02142 WILLIAM HULME CFO/TREASURER 8007579881 2023-11-14 1 WILLIAM HULME 000006658 0 HARRY A KALAJIAN JR CPA P00464296 6174399700 2023-11-14 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z X BREAK THROUGH CANCER WILLIAM HULME 101 ROGERS STREET CAMBRIDGE MA 02142 27161244 0 X HTTPS://BREAKTHROUGHCANCER.ORG X 2020 DE BREAK THROUGH CANCER IS A FOUNDATION DEDICATED TO SUPPORTING TRANSLATIONAL RESEARCH IN THE MOST DIFFICULT TO TREAT CANCERS. OUR PARTNER ORGANIZATIONS ARE AMONG THE TOP CANCER RESEARCH CENTERS AND TOGETHER, REPRESENT SOME OF THE MOST BRILLIANT, CREATIVE MINDS IN THE COUNTRY. WE BELIEVE BREAK THROUGH CANCER IS THE BEGINNING OF A SCIENTIFIC MOVEMENT THAT ACCEPTS NOTHING LESS THAN MULTI-INSTITUTIONAL COLLABORATION IN PATIENT CENTRIC CANCER RESEARCH. THE FOUNDATION WILL WORK CLOSELY WITH TEAMS OF SCIENTISTS, ENGINEERS, AND CLINICAL RESEARCHERS TO FOCUS ON DIAGNOSING, TREATING, AND IDEALLY CURING SOME OF THE MOST INTRACTABLE FORMS OF CANCER. WHILE MANY PATIENTS HAVE BENEFITED FROM ADVANCES IN RESEARCH AND TECHNOLOGY, THERE ARE FAR TOO MANY WHO HAVE BEEN LEFT BEHIND. THERE ARE TOO MANY CANCERS WHERE THE NEEDLE REMAINS UNMOVED. BREAK THROUGH CANCER IS COMMITTED TO MAKING HEADWAY IN THESE EXTREMELY COMPLEX, CHALLENGING DISEASES, AND COMMITTED TO FINDING HOPE FOR PATIENTS AND THEIR FAMILIES. 13 10 14 13 0 0 99557530 27158045 0 0 157618 3199 0 0 99715148 27161244 0 0 0 0 1282866 2366871 0 0 0 228552 21924803 1511418 24291674 98203730 2869570 98272406 102328231 68677 1254932 98203729 101073299 X BREAK THROUGH CANCER IS A FOUNDATION DEDICATED TO SUPPORTING TRANSLATIONAL RESEARCH IN THE MOST DIFFICULT TO TREAT CANCERS. OUR PARTNER ORGANIZATIONS ARE AMONG THE TOP CANCER RESEARCH CENTERS AND TOGETHER, REPRESENT SOME OF THE MOST BRILLIANT, CREATIVE MINDS IN THE COUNTRY. WE BELIEVE BREAK THROUGH CANCER IS THE BEGINNING OF A SCIENTIFIC MOVEMENT THAT ACCEPTS NOTHING LESS THAN MULTI-INSTITUTIONAL COLLABORATION IN PATIENT CENTRIC CANCER RESEARCH. THE FOUNDATION WILL WORK CLOSELY WITH TEAMS OF SCIENTISTS, ENGINEERS, AND CLINICAL RESEARCHERS TO FOCUS ON DIAGNOSING, TREATING, AND IDEALLY CURING SOME OF THE MOST INTRACTABLE FORMS OF CANCER. WHILE MANY PATIENTS HAVE BENEFITED FROM ADVANCES IN RESEARCH AND TECHNOLOGY, THERE ARE TOO MANY WHO HAVE BEEN LEFT BEHIND. THERE ARE TOO MANY CANCERS WHERE THE NEEDLE REMAINS UNMOVED. BREAK THROUGH CANCER IS COMMITTED TO MAKING HEADWAY IN THESE EXTREMELY COMPLEX, CHALLENGING DISEASES, AND COMMITTED TO FINDING HOPE FOR PATIENTS AND THEIR FAMILIES. 0 0 22332239 0 27161244 PROVIDES FUNDING TO TEAMS OF RESEARCHERS FROM THE FIVE TOP CANCER RESEARCH CENTERS: DANA-FARBER CANCER INSTITUTE, THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHN HOPKINS, MASSACHUSETTS INSTITUTE OF TECHNOLOGY'S KOCH INSTITUTE FOR INTEGRATIVE CANCER RESEARCH, THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER, AND MEMORIAL SLOAN KETTERING CANCER CENTER IN ORDER TO HELP INTERCEPT CANCER EARLY, DEVELOP MORE EFFECTIVE TREATMENTS, AND ACCELERATE CURES FOR SOME OF THE DEADLIEST CANCERS. 22332239 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 10 0 1 14 1 0 0 0 0 0 0 0 0 0 0 X 13 10 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 1 1 0 MA NY MD SC CT VA X WILLIAM HULME 8007579881 101 ROGERS STREET CAMBRIDGE MA 02142 BILL GOODWIN DIRECTOR 1.00 X 0 0 0 ALICE GOODWIN DIRECTOR 1.00 X 0 0 0 JOHN SHERMAN DIRECTOR 1.00 X 0 0 0 SUSAN HOCKFIELD DIRECTOR 1.00 X 0 0 0 GIULIO DRAETTA DIRECTOR 1.00 X 0 0 0 DAVID JAFFRAY DIRECTOR 1.00 X 0 0 0 BILL NELSON CHAIRMAN 1.00 X 0 0 0 DAVID SCHEINBERG DIRECTOR 1.00 X 0 0 0 CRAIG THOMPSON DIRECTOR 1.00 X 0 0 0 LISA DEANGELIS DIRECTOR 1.00 X 0 0 0 LAURIE GLIMCHER DIRECTOR 1.00 X 0 0 0 BILL HAHN DIRECTOR 1.00 X 0 0 0 LIZ JAFFEE DIRECTOR 1.00 X 0 0 0 LISA SCHWARZ COO/CPO/SECRETARY 40.00 X 255235 0 39083 WILLIAM HULME CFO/TREASURER 40.00 X 201275 0 10738 TYLER JACKS PRESIDENT 20.00 X 250000 0 13190 JESSE BOEHM CHIEF SCIENCE OFFICER 40.00 X 240482 0 38482 KARI MCHUGH CHIEF COMMUNICATIONS OFFICER 40.00 X 187913 0 28204 MICHEAL NOBLE CHIEF DATA OFFICER 40.00 X 145826 0 16954 1280731 0 146651 6 0 1 0 WILSON SONSINI GOODRICH & ROSATI PC ONE BOSTON PLACE 201 WASHINGTON ST BOSTON MA 02108 LEGAL SERVICES 136519 1 27158045 27158045 3199 3199 27161244 0 0 3199 1280731 685860 594871 765845 410127 355718 1881 194 1687 203367 62958 140409 115047 43436 71611 212316 212316 29750 29750 3730 3730 65273 65273 19873 6833 13040 80105 24737 55368 186337 56215 130122 44709 11436 33273 431796 421267 10529 14361 5052 9309 PROJECT SPENDING EXPENS 20501589 20501589 OFFICE FURNITURE & EQUI 229002 63371 165631 CONTRACTED SERVICES 73306 28060 45246 MEALS AND ENTERTAINMENT 13795 5083 8712 18861 6021 12840 24291674 22332239 1959435 0 929560 4221469 97341409 97090208 1437 4378 0 1012176 98272406 102328231 68677 234833 0 1020099 68677 1254932 X 18840542 32830999 79363187 68242300 98203729 101073299 98272406 102328231 2869570 0 X X 0 1 X 1 0 X 267646 353546 6048946 6670138 267646 353546 6048946 6670138 6670138 157618 3199 160817 6830955 X SCHEDULE A, PART II, LINE 13: THE ORGANIZATION WAS FORMED ON 4/28/2020. A SHORT YEAR RETURN WAS FILED FOR THE 2020 TAX YEAR. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 LEASE LIABILITY 1020099 1020099 X 27161244 0 27161244 0 27161244 24291674 0 24291674 0 24291674 PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN RECORDED IN THE ACCOMPANYING FINANCIAL STATEMENTS. TAX POSITIONS, INCLUDING THE POSITION THAT THE ORGANIZATION QUALIFIES AS A TAX-EXEMPT ENTITY, TAKEN OR EXPECTED TO BE TAKEN IN THE COURSE OF PREPARING THE ORGANIZATION'S TAX RETURNS ARE REQUIRED TO BE EVALUATED TO DETERMINE WHETHER THE TAX POSITIONS ARE "MORE-LIKELY-THAN-NOT" OF BEING SUSTAINED BY THE APPLICABLE TAX AUTHORITY. TAX POSITIONS NOT DEEMED TO MEET A MORE-LIKELY-THAN-NOT THRESHOLD WOULD BE RECORDED AS A TAX EXPENSE IN THE CURRENT YEAR. THE ORGANIZATION DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS AT DECEMBER 31, 2022 WHICH REQUIRE ACCRUAL OR DISCLOSURE. GENERALLY, THE ORGANIZATION IS SUBJECT TO FEDERAL AND STATE TAX EXAMINATION BY TAX AUTHORITIES SINCE ITS INCEPTION. THE ORGANIZATION'S POLICY IS TO RECOGNIZE ANY INTEREST AND PENALTIES RELATED TO TAX MATTERS AS AN EXPENSE IN THE STATEMENT OF ACTIVITIES. X 0 0 0 0 0 0 0 0 0 LISA SCHWARZ COO/CPO/SECRETARY 255235 0 0 0 0 0 12692 0 26391 0 294318 0 0 0 JESSE BOEHM CHIEF SCIENCE OFFICER 240482 0 0 0 0 0 11967 0 26515 0 278964 0 0 0 TYLER JACKS PRESIDENT 250000 0 0 0 0 0 12500 0 690 0 263190 0 0 0 KARI MCHUGH CHIEF COMMUNICATIONS OFFICER 187913 0 0 0 0 0 9179 0 19025 0 216117 0 0 0 WILLIAM HULME CFO/TREASURER 201275 0 0 0 0 0 10020 0 718 0 212013 0 0 0 MICHEAL NOBLE CHIEF DATA OFFICER 145826 0 0 0 0 0 7250 0 9704 0 162780 0 0 0 PART I, LINE 3 OUR PROCESS FOR HIRING IS TO PERFORM A MARKET ANALYSIS FOR THE POSITION WE ARE HIRING TO DETERMINE THE SALARY RANGE. IT INVOLVES RECEIVING INFORMATION FROM BOTH ACADEMIC ORGANIZATIONS AND INDUSTRY. THE INFORMATION IS GATHERED BY THE COO AND REVIEWED WITH THE CFO. COMMONWEALTH FOUNDATION FOR CANCER RESEARCH BOARD MEMBERS OF CFCR 21109099 JOHN SHERMAN, ALICE GOODWIN AND BILL GOODWIN, THE BOARD MEMBERS OF THE ORGANIZATION, ARE ALSO BOARD MEMBERS OF COMMONWEALTH FOUNDATION FOR CANCER RESEARCH (CFCR). IN 2022, CFCR CONTRIBUTED $21,109,099 TO COMMONWEALTH CANCER CONSORTIUM INCLUDED PLEDGE AND MATCHING GRANTS. 0 FORM 990, PART VI, SECTION A, LINE 2 TWO BOARD MEMBERS ARE SPOUSES. THREE BOARD MEMBERS ARE ALSO SERVE ON THE BOARD OF COMMONWEALTH FOUNDATION FOR CANCER RESEARCH. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS PROVIDED TO THE BOARD FOR THEIR REVIEW BEFORE FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION HAS A CONFLICT OF INTEREST POLICY IN PLACE. THE BOARD MEMBERS REVIEW THE CONFLICT OF INTEREST POLICY ANNUALLY. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION WILL PERFORM A MARKET ANALYSIS FOR EACH POSITION TO DETERMINE THE SALARY RANGE WHICH INVOLVES RECEIVING INFORMATION FROM BOTH ACADEMIC ORGANIZATIONS AND INDUSTRY. THE INFORMATION IS GATHERED BY THE COO AND REVIEWED WITH THE CFO. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATIONS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART XII, LINE 2C: THERE WAS NO CHANGE IN THE OVERSIGHT PROCESS OR SELECTION PROCESS DURING THE TAX YEAR OF 2022.